Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
R Soc Open Sci ; 3(1): 150111, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26909161

ABSTRACT

Leafcutter ants cut trimmings from plants, carry them to their underground nests and cut them into smaller pieces before inoculating them with a fungus that serves as a primary food source for the colony. Cutting is energetically costly, so the amount of cutting is important in understanding foraging energetics. Estimates of the cutting density, metres of cutting per square metre of leaf, were made from samples of transported leaf cuttings and of fungal substrate from field colonies of Atta cephalotes and Atta colombica. To investigate cutting inside the nest, we made leaf-processing observations of our laboratory colony, A. cephalotes. We did not observe the commonly reported reduction of the leaf fragments into a pulp, which would greatly increase the energy cost of processing. Video clips of processing behaviours, including behaviours that have not previously been described, are linked. An estimated 2.9 (±0.3) km of cutting with mandibles was required to reduce a square metre of leaf to fungal substrate. Only about 12% (±1%) of this cutting took place outside of the nest. The cutting density and energy cost is lower for leaf material with higher ratios of perimeter to area, so we tested for, and found that the laboratory ants had a preference for leaves that were pre-cut into smaller pieces. Estimates suggest that the energy required to transport and cut up the leaf material is comparable to the metabolic energy available from the fungus grown on the leaves, and so conservation of energy is likely to be a particularly strong selective pressure for leafcutter ants.

2.
Am J Physiol Lung Cell Mol Physiol ; 301(5): L645-55, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21856819

ABSTRACT

Prostaglandin E(2) (PGE(2)) is a lipid mediator that is produced via the metabolism of arachidonic acid by cyclooxygenase enzymes. In the lung, PGE(2) acts as an anti-inflammatory factor and plays an important role in tissue repair processes. Although several studies have examined the role of PGE(2) in the pathogenesis of pulmonary fibrosis in rodents, results have generally been conflicting, and few studies have examined the therapeutic effects of PGE(2) on the accompanying lung dysfunction. In this study, an established model of pulmonary fibrosis was used in which 10-12-wk-old male C57BL/6 mice were administered a single dose (1.0 mg/kg) of bleomycin via oropharyngeal aspiration. To test the role of prostaglandins in this model, mice were dosed, via surgically implanted minipumps, with either vehicle, PGE(2) (1.32 µg/h), or the prostacyclin analog iloprost (0.33 µg/h) beginning 7 days before or 14 days after bleomycin administration. Endpoints assessed at 7 days after bleomycin administration included proinflammatory cytokine levels and measurement of cellular infiltration into the lung. Endpoints assessed at 21 days after bleomycin administration included lung function assessment via invasive (FlexiVent) analysis, cellular infiltration, lung collagen content, and semiquantitative histological analysis of the degree of lung fibrosis (Ashcroft method). Seven days after bleomycin administration, lymphocyte numbers and chemokine C-C motif ligand 2 expression were significantly lower in PGE(2)- and iloprost-treated animals compared with vehicle-treated controls (P < 0.05). When administered 7 days before bleomycin challenge, PGE(2) also protected against the decline in lung static compliance, lung fibrosis, and collagen production that is associated with 3 wk of bleomycin exposure. However, PGE(2) had no therapeutic effect on these parameters when administered 14 days after bleomycin challenge. In summary, PGE(2) prevented the decline in lung static compliance and protected against lung fibrosis when it was administered before bleomycin challenge but had no therapeutic effect when administered after bleomycin challenge.


Subject(s)
Bleomycin/adverse effects , Collagen/biosynthesis , Dinoprostone/pharmacology , Iloprost/pharmacology , Lung/drug effects , Pulmonary Fibrosis/drug therapy , Animals , Bleomycin/administration & dosage , Bronchoalveolar Lavage Fluid/cytology , Collagen/analysis , Cytokines/biosynthesis , Dinoprostone/metabolism , Disease Models, Animal , Drug Administration Schedule , Histocytochemistry , Humans , Iloprost/metabolism , Infusion Pumps, Implantable , Leukocyte Count , Lung/metabolism , Lung/pathology , Male , Mice , Mice, Inbred C57BL , Neutrophil Infiltration , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/metabolism , Pulmonary Fibrosis/pathology , Pulmonary Fibrosis/physiopathology , Pulmonary Fibrosis/prevention & control , Real-Time Polymerase Chain Reaction , Severity of Illness Index
3.
Risk Anal ; 31(5): 773-86, 2011 May.
Article in English | MEDLINE | ID: mdl-21231940

ABSTRACT

We examine the reduction in London Underground passenger journeys in response to the July 2005 bombings. Using entrance data for London Underground stations between 2001 and 2007, we incorporate demand and supply factors in a multivariate time-series regression model to estimate changes in passenger journeys between different Underground lines. We find that passenger journeys fell by an average of 8.3% for the 4 months following the attacks. This amounts to an overall reduction of 22.5 million passenger journeys for that period. Passenger journeys returned to predicted levels during September 2005, yet we find evidence of reduced travel until June 2006. Our estimates controlled for other factors, including reduced Underground service provision due to damage from the attacks, economic conditions, and weather, yet substantial reductions in passenger journeys remained. Around 82% of passenger journey reductions following the 2005 attacks cannot be attributed to supply-side factors or demand-side factors such as economic conditions, weather, or the summer school-break alone. We suggest that this reduction may partially be due to an increased perception of the risk of Underground travel after the attacks.


Subject(s)
Transportation , Humans , London , Risk Assessment , Terrorism
4.
J Surg Res ; 164(2): 221-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-19932898

ABSTRACT

Common bile duct (CBD) ligation is used in animal models to induce biliary inflammation, fibrosis, and cholestatic liver injury, but results in a high early postoperative mortality rate, probably from traumatic pancreatitis. We modified the CBD ligation model in mice by placing a small metal clip across the lower end of the CBD. To reverse biliary obstruction, a suture was incorporated within the clip during its placement. The suture and clip were removed on postoperative d 5 or 10 for biliary decompression. After 5 d of biliary obstruction, the gallbladder showed an 8-fold increase in wall thickness and a 17-fold increase in tissue myeloperoxidase activity. Markedly elevated serum levels of alkaline phosphatase and bilirubin indicated injury to the biliary epithelium and hepatocytes. Early postoperative (d 0-2) survival was 100% and later (d 3-5) survival was 85% (n=54 mice). We successfully reversed biliary obstruction in 20 mice (37%). Overall survival after reversal was 70%. In surviving mice, biliary decompression was complete, inflammation was reduced, and jaundice resolved. Histologic features confirmed reduced epithelial damage, edema, and neutrophil infiltration. Our technique minimized postoperative death, maintained an effective inflammatory response, and was easily reversible without requiring repeat laparotomy. This reversible model can be used to further define molecular mechanisms of biliary inflammation, fibrosis, and liver injury in genetically altered mice.


Subject(s)
Gallbladder Diseases/surgery , Inflammation/surgery , Jaundice, Obstructive/surgery , Alkaline Phosphatase/blood , Animals , Bilirubin/blood , Common Bile Duct/surgery , Male , Mice , Mice, Inbred Strains , Peroxidase/metabolism , Postoperative Complications/pathology , Postoperative Complications/prevention & control , Surgical Instruments
5.
J Surg Res ; 136(2): 182-6, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17054993

ABSTRACT

BACKGROUND: The major technical challenge of liver surgery is controlling bleeding during transection of the parenchyma. The Gyrus hand piece (GHP) is a bipolar diathermy pulsation instrument that is similar in design to a large hemostat (Péan) clamp that divides tissue while the clamp remains closed. MATERIALS AND METHODS: We retrospectively analyzed the peri-operative data from 10 patients with early cirrhosis (stage 1-4) who underwent liver resection for hepatocellular cancer between February 2004 and July 2005. Five consecutive patients who underwent resection using the GHP were compared to five other patients who underwent resection using the traditional "crush clamp technique" (CCT). Six patients underwent minor hepatectomy (<3 segments) and four underwent major hepatectomy (>3 segments). RESULTS: When the GHP was used, the mean Pringle time was 13 +/- 5 min, mean blood loss was 520 mL +/- 118, and mean operative time was 252 +/- 15 min. When the CCT was used, the average Pringle time was 13 +/- 3 min, mean blood loss was 630 +/- 67 mL, and mean operative time was 312 +/- 29 min. There were 2 major complications in the GHP group and 3 in the CCT group. Major complications included transient hepatic failure (i.e., ascites/encephalopathy) and biloma formation. CONCLUSIONS: One patient from each group suffered a minor wound complication. The average hospital stay was 8 days (range, 6-9) for the GHP group, and 8 days (range, 7-10) for CCT group. The operative mortality rate was 0%. Our preliminary results demonstrate that GHP provides an excellent and safe alternative to CCT for dividing the liver parenchyma in cirrhotic patients.


Subject(s)
Blood Loss, Surgical/prevention & control , Hepatectomy/methods , Laser Coagulation/methods , Liver Cirrhosis/surgery , Carcinoma, Hepatocellular/surgery , Hepatectomy/instrumentation , Humans , Laser Coagulation/instrumentation , Liver Circulation , Liver Neoplasms/surgery , Retrospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...